Search

Search Constraints

You searched for: Author/Creator Kohn, Anna

Search Results

2. The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar. Issue 2 (13th January 2017)

3. Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II). Issue 1 (15th December 2017)

4. AIGO research output: A potential matter for postgraduate non-academic hospital specialist training in gastroenterology. Issue 10 (October 2020)

5. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)

8. Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study. (1st December 2014)

9. The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy. Issue 3 (21st February 2019)